chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle pain unable to use both arms; Back muscle pain; Ankle and knee governing out on both sides; Ankle and knee governing out on both sides; Muscles sore and barely usable; This is a spontaneous report from a contactable Other HCP. This 41-year-old female Other HCP reported.  A 41-year-old (non-pregnant) female patient received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered in left arm on 05Feb2021 (at the age of 41-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  On 0Feb2021 11:30 AM, after the vaccination, the patient experienced Muscles sore and barely usable, Muscle pain unable to use both arms. Ankle and knee governing out on both sides. Back muscle pain. No other vaccines were taken in four weeks of vaccination. No other medications were taken in two weeks. Patient was not found with covid prior vaccination. Covid test was not done post vaccination. No known allergies. The outcome of the events is not recovered.  No follow-up attempts possible. No further information expected.  Follow-up (01Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Within 1 hour of injection a knot the size of a quarter manifested that was red. The site was very painful. overtime the lymph nodes axilla enlarger. The lymph node swelling persisted for 6 days. As of today, June 10th, 2022, the knot, now smaller and redness persists.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 56-year-old male patient who received SHINGRIX for prophylaxis. On 28th August 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The patient presented with soreness in arm. The reporter did not consent to follow up. There was no contact. For tolerance to 2nd dose, refer case US2018GSK203632.
Pt experienced swelling and decrease in respiratory functions and decrease in cardiovascular functions. Dr ordered steroids and antihistamines and follow-up at ER.
Nov - chest cold, achy, fever, extremely tired, felt like someone hit her in back. Dr treated for respiratory infection. Took Rx and felt good off and on until Jan 03; saw Dr in Jan because teeth hurt so much - treated for infection with Zithromax. Took meds and continued mouth pain with low grade fever; saw Dr Feb 12.
Redness around injection site and minor swelling the night of the 03/29/2019 and painful when the thigh was touched. The next day around noon, the red area had spread and the thigh was still swollen. On 03/31/2019 the redness spread further, almost around to the back of the thigh and down to the knee and whole upper thigh was swollen to knee. Not firm and did not seem to be painful.
8 days after the initial dose my arm has become hard and swollen at the injection site, plus I have had a headache all day and needed to take 400mg ibuprofen. I had no reactions until today, which seems odd.
swelling almost the size of a golf ball now; Painful left arm; hot to the touch; itching; swelling; redness; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling almost the size of a golf ball now), PAIN IN EXTREMITY (Painful left arm), VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swelling) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included LISINOPRIL for Blood pressure, ATORVASTATIN for Cholesterol, PANTOPRAZOLE for Gastrooesophageal reflux disease, ACETYLSALICYLIC ACID (ASPIRIN 81) for Heart disease, unspecified, MAGNESIUM and BIOTIN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced SWELLING (swelling almost the size of a golf ball now), PAIN IN EXTREMITY (Painful left arm), VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness). On 20-Feb-2021, SWELLING (swelling almost the size of a golf ball now), PAIN IN EXTREMITY (Painful left arm), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness) had resolved. At the time of the report, VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-034040, MODERNATX, INC.-MOD-2021-034040 (E2B Linked Report). This case was linked to MOD-2021-100039, MOD-2021-100039 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Agency form; Sender's Comments:  MOD-2021-034040:Crosslinked, Husband case US-MODERNATX, INC.-MOD-2021-034040:Wife's case
With in 6 hours pt developed moderately debilitating lymphadenopathy described as severe pain at the axillary aspect of the arm and engorged lymph nodes. Pt also developed a mild site reaction, pt was treated with Fiorinal. She lost 4 nights of sleep.
Medical assistant calling to report a temperature excursion that occurred 8/14/2020 which involved the following products: GARDASIL9, PEDVAXHIB, RECOMBIVAX, ROTATEQ. Per caller, "it would be possible that at least 100 patients have received vaccines; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies or concomitant medications were not reported.  On 26-AUG-2020, the patient was vaccinated with an improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally as prophylaxis (lot # 1660991 with expiration date 27-APR-2021) (strength and frequency were not reported) and with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 ml as prophylaxis (lot # S036821 with expiration date 21-APR-2022) (strength, frequency, route of administration and anatomical location were not reported).  The improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced a temperature excursion of 35.4 Fahrenheit degrees (°F) for the time frame of 20 minutes without previous temperature excursions. It was confirmed that a digital data logger was involved.  This is one of several cases from the same reporter. ; Sender's Comments:  US-009507513-2009USA006106:
Vomiting; diarrhea; This is a spontaneous report from a contactable consumer reporting for herself.   A 44-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, lot # Ek5730) at single dose to right arm on 22Dec2020 for Covid-19 immunisation.   Medical history and concomitant medications were none.  The patient experienced severe reaction of vomiting and diarrhea on 24Dec2020, about 48 hours after vaccination, lasted about 7 hours, it went away on 24Dec2020, and she has recovered completely, but it took days to get back to normal. The outcome of events was recovered on 24Dec2020. She queried if it is safe to get the 2nd dose, if it makes her feel like the 1st one, she doesn't want it.
After first shot my knee went down hill; This spontaneous case was reported by a consumer and describes the occurrence of ARTHROPATHY (After first shot my knee went down hill) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee surgery NOS (Underwent left knee surgery (torn meniscus)) in November 2020, Back surgery, Neck surgery, Hand operation, Wrist surgery, Toe operation (Underwent right toe surgery), Ankle operation and Surgery (Underwent left thumb surgery). Concurrent medical conditions included Chronic pain (Had chronic pain all over his body from the past surgeries) and Hypothyroidism (Low Thyroid Level). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, PARACETAMOL (TYLENOL [PARACETAMOL]) and IBUPROFEN for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHROPATHY (After first shot my knee went down hill). At the time of the report, ARTHROPATHY (After first shot my knee went down hill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment drugs were reported  This case concerns a 61-year-old, male patient, with medical history of knee surgery, who experienced the non-serious, unexpected event of arthropathy. The event occurred  on unspecified date after first dose of mRNA 1273 vaccine. The rechallenge is unknown as the outcome of event is unknown. The patient's history of knee surgery remains a confounder to the event. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.   This case was linked to MOD-2021-374096 (Patient Link).; Sender's Comments: This case concerns a 61-year-old, male patient, with medical history of knee surgery, who experienced the non-serious, unexpected event of arthropathy. The event occurred  on unspecified date after first dose of mRNA 1273 vaccine. The rechallenge is unknown as the outcome of event is unknown. The patient's history of knee surgery remains a confounder to the event. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
Patient hospitalized for labor/delivery and was given IM Tdap (Adacel) vaccination at 9:30pm on 10/01/10. No previous history of allergies documented. Severe rash with straie developed on patient's arms and legs, including on hands and feet. Unrelieved with Benadryl (given every 6 hours). Patient improved with Vistaril. Undocumented mild shortness of breath, but relieved. Patient left hospital on 10/02/2010 with rash, but recieved with medication.
Resident given a vaccine (Maderna) on 9-8-2021 that was opened on 9-1-2021
After 12 + hours I felt a headache (like a sinus headache),  In addition I experienced fatigue, light headedness, and mild sense of nausea.  It felt like I had Covid again, but to a lesser degree.
Patient reports swollen tongue and urticaria of mouth 30 minutes after receiving the vaccine. Patient self-administered oral benadryl at that time, and self-administered every 4 - 6 hrs for 24 hours. Tongue swelling resolved within 24 hours, but urticaria persisted.
Muscles around heart rapidly spasmed for approximately an hour. I felt a sense of dread and nausea. Spasms stopped and started during the hour I was affected.
ABDOMINAL PAIN; BRUISES ON LEG AND RIGHT ARM; CRAMPING ON LEG; This spontaneous report received from a consumer concerned a 60 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included Lyme disease, shellfish allergy, allergy to an unknown antibiotic, non alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced abdominal pain. On 12-APR-2021, the subject experienced bruises on leg and right arm. On 12-APR-2021, the subject experienced cramping on leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from abdominal pain, bruises on leg and right arm, and cramping on leg. This report was non-serious.; Sender's Comments: v0-Medical assessment comment is not required as the case is assessed as non-serious.
PER PC FROM MOTHER ON 11/5/10, PT HAD VOMITING, FEVER, RED ITCHY SPOTS ON GROIN AND UNDERARM AREA SINCE EVENING OF 11/3/10
Hospitalization PARMC IP provided pt information; pt admitted to hospital with acute hypoxemic respiratory failure secondary to COVID-19. Pt received remdesivir treatment in addition to oxygen and other medications. No ventilator, ECMO, or ICU admission.
Pt fainted in waiting area after her vaccine. She was fine after I tended to her. It was about 5 min after her vaccination. After talking to her, it was determined that she has anxiety and she has fainted with blood draws in the past.
Hep B vac given on 5/1/12; client noticed in the evening swollen area between clavicle & trachea approx size of small plum this AM. He denies any other symptoms, SOB, difficulty breathing or swallowing. Is a little tender to touch. Advice f/u with PCP today.
Subendocardial Myocardial Infarction  three days after the second dose.  Heart function appears preserved.
Headache, fever, chills, stuffy nose, slight cough, tiredness.  All less than 24 hours after receiving shot.  Headache, tiredness, slight cough, stuffy nose still less than 48 hours later.
Inflammation after vaccination; Pinched Nerve after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflammation after vaccination) and NERVE COMPRESSION (Pinched Nerve after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (Inflammation after vaccination) and NERVE COMPRESSION (Pinched Nerve after vaccination). At the time of the report, INFLAMMATION (Inflammation after vaccination) and NERVE COMPRESSION (Pinched Nerve after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient treatment data was not provided.
Painful, swollen lymph nodes in L chest; Painful, swollen lymph nodes in L chest; arm pit, muscle aches; arm pit, muscle aches; This is a spontaneous report from a contactable nurse (patient) reporting for herself.  A 37-year-old female (not pregnant at the time of vaccination) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0140), via an unspecified route of administration at left arm on 24Dec2020 09:30 at single dose for COVID-19 immunization at a hospital. The patient's medical history included hypertension, depression and anxiety. No known allergies to medications, food, or other products. Concomitant medication included alprazolam (XANAX), diclofenac (VOLTAREN), bupropion hydrochloride (WELLBUTRIN XL), amlodipine besilate (NORVASC), and diphenhydramine hydrochloride (BENADRYL). No other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested for COVID-19 post the vaccination. On 25Dec2020 05:00, the patient experienced painful, swollen lymph nodes in left (L) chest, and arm pit, muscle aches. No treatment was taken for the above events. The outcome of the events was recovering.
Myalgia, Fever, MALAISE Narrative: History: Employee got the second dose covid vaccine 01/27/21 0845am He claimed that later in the day he developed chills, malaise, bodyache, tiredness, body pain Missed work 01/28/2021
FLU SHOT ADMINISTERED TO LEFT DELTOID IM GIVEN HIGHER ON THE ARM THAN USUAL IMMEDIATE PAIN DOWN TO FINGERTIPS MUSCLE ACHES WITH SHOOTING PAIN TO FINGERS DX'D BY RHEUMATOLOGY AS BURSITIS  TX'D W/ STEROID INJECTIOS ON 11/16/23
Redness that continues to spread at the injection site. Pain at the injection site. Dull headache.
Narrative: Patient was due to receive Moderna Bivalent COVID  vaccine, but he received Moderna Monovalent COVID vaccine instead.
a steadily increase on his blood sugar; This is a spontaneous report from a contactable consumer reporting for himself. A male patient of an unspecified age received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. On an unspecified date after receiving the vaccine, the patient experienced a steadily increase on his blood sugar which arrived to glucose values nearing 575. The  patient would like to note there was no change in his diet or routine, and his conclusion was that it had to be a possible side effect from the vaccine. The outcome of the event a steadily increase on his blood sugar was not recovered.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
arm pain( lastweek with moderna vaccine i had some arm pain that not radiate); A spontaneous report was received from a consumer concerning a unknow years old,  patient who developed/experienced arm pain (pain in extremities).  The patient's medical history included cervical neck issue with headache.Concomitant product use was not provided by the reporter. Concomitant product use was not provided by the reporter.   On ?? Dec 2020, the patient received their first of two planned doses of mRNA-1273 batch number not provided intramuscularly for prophylaxis of COVID-19 infection.   On ?? Dec 2020, the patient experienced arm pain.   Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not provided.  The event lymphadenopathy was considered not recovered.
Received Td 09/17/01 left deltoid c/o deep pain since. Exam shows mild atrophy. No response to NSAIDs, Cox-2 inhib
Virus: congestion, sore throat, fever, nausea, diarrhea all for at least 7 days plus and ongoing.  MD says treat with Tylenol. Treating at home with oil of oregano, colloidal silver, vitamin C to support immune system.
Information has been received from a physician referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant medication was not reported. On 19-OCT-2015 the patient was vaccinated with dose of improperly stored ROTATEQ (lot # L008031) with expiration date of 03-AUG-2016; strength, dosage and frequency unspecified) orally. No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
8/13/2021: The patient reports that she is feeling lethargic with a low-grade temperature.  Because of that and her immunosuppressive status, the patient went to the hospital for evaluation on 8/13 and was admitted. Test was positive for COVID-19 on 8/13/21.  Diagnosed with acute covid 19 infection, hypoxic respiratory failure secondary to viral pneumonia.  Note: previously received the Pfizer COVID-19 vaccine; First Dose: 03/11/21 Lot Number EN6208;Second Dose: 04/05/21 Lot Number EP6955 8/17/21: Discharged to home.
severe lethargy, vomiting, chills, nausea, headache, all came on suddenly around 24 hours after the second Moderna vaccine. 24 hours later, symptoms still exist. I have call the Moderna 24/7 phone line and NO RETURN CALL.  All I was able to do was leave a voicemail.
Pt received Zostavax on 08/10/09 at 9:30am. She noticed area of injection site was red and itchy on 08/11/09 in AM. Today (08/12/09) she has erythematous patch measuring 6cm x 3 cm in right posterior upper arm, near posterior region of deltoid. Patch is warm and TTP. Not indurated. No lymphangitis. No right axillary lymphandenopathy.
Patient got weak and dizzy- sent to hospital by ambulance but caregiver called back in the afternoon and said patient was ok. His blood pressure was low but is now ok.
This spontaneous case was reported by a consumer and describes the occurrence of NEPHROTIC SYNDROME (experiencing nephrotic syndrome) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEPHROTIC SYNDROME (experiencing nephrotic syndrome) (seriousness criterion medically significant). At the time of the report, NEPHROTIC SYNDROME (experiencing nephrotic syndrome) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No adverse event as Medical History was reported.  Treatment of events was not reported. Concomitant medication use was not provided by the reporter. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Company Comment: Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Balance issues; weakness; stiffness; lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Balance issues), ASTHENIA (weakness), MUSCULOSKELETAL STIFFNESS (stiffness) and DIZZINESS (lightheadedness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 027L20A) for COVID-19 vaccination.     Concomitant products included CHLORDIAZEPOXIDE HYDROCHLORIDE, CLIDINIUM BROMIDE (LIBRAX [CHLORDIAZEPOXIDE HYDROCHLORIDE;CLIDINIUM BROMIDE]), OMEPRAZOLE, VORTIOXETINE HYDROBROMIDE (TRINTELLIX), METOPROLOL TARTRATE, DIAZEPAM (VALIUM), OLMESARTAN, ESTROGENS CONJUGATED (ESTROGENON), MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC), PARACETAMOL (TYLENOL), VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (Balance issues), ASTHENIA (weakness), MUSCULOSKELETAL STIFFNESS (stiffness) and DIZZINESS (lightheadedness). At the time of the report, BALANCE DISORDER (Balance issues), ASTHENIA (weakness), MUSCULOSKELETAL STIFFNESS (stiffness) and DIZZINESS (lightheadedness) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-047053 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received. Reporter address and email updated.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.